DreamCIS, Inc. (KOSDAQ:223250)
South Korea · Delayed Price · Currency is KRW
5,010.00
-10.00 (-0.20%)
At close: Apr 24, 2026
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| | | -1.72B | -576.65M | - | - | - |
| | | 15.14B | 7.25B | - | - | - |
Medical Consulting Growth | | | 108.86% | - | - | - | - |
Clinical Trial Management Agency | | | 34.42B | 32.20B | - | 23.49B | 22.11B |
Clinical Trial Management Agency Growth | | | 6.90% | - | - | 6.24% | - |
| | | 47.84B | 38.87B | - | 23.49B | 22.11B |
| | | 23.08% | - | - | 6.24% | - |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| | | 43.36B | 34.24B | 23.24B | 20.50B | 18.68B |
| | | 26.62% | 47.34% | 13.38% | 9.71% | - |
| | | 4.49B | 4.63B | 2.91B | 2.99B | 3.42B |
| | | -3.11% | 58.96% | -2.63% | -12.65% | - |
| | | 47.84B | 38.87B | 26.15B | 23.49B | 22.11B |
| | | 23.08% | 48.64% | 11.34% | 6.24% | - |
Source: S&P Global Market Intelligence.
